BAXTER HLTHCARE CORP FDA Approval NDA 018799

NDA 018799

BAXTER HLTHCARE CORP

FDA Drug Application

Application #018799

Application Sponsors

NDA 018799BAXTER HLTHCARE CORP

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION300MG/ML0PRALIDOXIME CHLORIDEPRALIDOXIME CHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1982-12-13STANDARD

CDER Filings

BAXTER HLTHCARE CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18799
            [companyName] => BAXTER HLTHCARE CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"PRALIDOXIME CHLORIDE","activeIngredients":"PRALIDOXIME CHLORIDE","strength":"300MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PRALIDOXIME CHLORIDE","submission":"PRALIDOXIME CHLORIDE","actionType":"300MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.